Currently, the LH-RH analogs used clinically for the therapy of advanced prostate cancer include triptorelin (Decapeptyl, Trelstar)14, Leuprolide (Lupron, Eligard), buserelin (Suprefact, Suprecur) and goserelin (Zoladex). This evidence concerns the gene GNRH1 and prostate carcinoma.